Growth Metrics

Avanos Medical (AVNS) Leases (2019 - 2025)

Avanos Medical (AVNS) has disclosed Leases for 7 consecutive years, with $27.6 million as the latest value for Q4 2025.

  • Quarterly Leases fell 19.06% to $27.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27.6 million through Dec 2025, down 19.06% year-over-year, with the annual reading at $27.6 million for FY2025, 19.06% down from the prior year.
  • Leases hit $27.6 million in Q4 2025 for Avanos Medical, down from $29.9 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $45.1 million in Q1 2021 to a low of $24.2 million in Q1 2024.
  • Historically, Leases has averaged $32.2 million across 5 years, with a median of $30.5 million in 2025.
  • Biggest five-year swings in Leases: decreased 28.76% in 2022 and later soared 32.64% in 2025.
  • Year by year, Leases stood at $38.6 million in 2021, then fell by 28.76% to $27.5 million in 2022, then dropped by 2.55% to $26.8 million in 2023, then grew by 27.24% to $34.1 million in 2024, then dropped by 19.06% to $27.6 million in 2025.
  • Business Quant data shows Leases for AVNS at $27.6 million in Q4 2025, $29.9 million in Q3 2025, and $31.1 million in Q2 2025.